ArticleFrontiers in aging neuroscience2022
Deep Learning-Based Multilevel Classification of Alzheimer's Disease Using Non-invasive Functional Near-Infrared Spectroscopy.
Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.
- Diagnostic potential of near-infrared spectroscopy in mild cognitive impairment and neurodegenerative disorders: Implications for resource-limited settings.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Pooled it
- Functional near-infrared spectroscopy for identifying mild cognitive impairment and Alzheimer's disease: a systematic review.Frontiers in neurology · 2025Pooled it
- Identification of functional near-infrared spectroscopy for older adults with mild cognitive impairment: a systematic review.Frontiers in aging neuroscience · 2025Pooled it
- AI-Based Measurement Tools for Intrinsic Capacity in Older Adults: Scoping Review.Journal of medical Internet research · 2026Article
- Enhanced fNIRS-Based MCI Detection via Resting-State and Task-State Integration With Spatial-Temporal Feature Reduction.IEEE journal of translational engineering in health and medicine · 2026Article
- Alteration of prefrontal functional connectivity in preclinical Alzheimer's disease: an fNIRS study.Frontiers in aging neuroscience · 2025Article
- NiReject: toward automated bad channel detection in functional near-infrared spectroscopy.Neurophotonics · 2024Article
- Novel Feature Generation for Classification of Motor Activity from Functional Near-Infrared Spectroscopy Signals Using Machine Learning.Diagnostics (Basel, Switzerland) · 2024Article
- Multilevel Pain Assessment with Functional Near-Infrared Spectroscopy: Evaluating ΔSensors (Basel, Switzerland) · 2024Article
- A comprehensive research setup for monitoring Alzheimer's disease using EEG, fNIRS, and Gait analysis.Biomedical engineering letters · 2024Article
- Research on the application of functional near-infrared spectroscopy in differentiating subjective cognitive decline and mild cognitive impairment.Frontiers in aging neuroscience · 2024Article
- Artificial intelligence technology in Alzheimer's disease research.Intractable & rare diseases research · 2023Review
- An Isolated CNN Architecture for Classification of Finger-Tapping Tasks Using Initial Dip Images: A Functional Near-Infrared Spectroscopy Study.Bioengineering (Basel, Switzerland) · 2023Article
- Use of Hypoxic Respiratory Challenge for Differentiating Alzheimer's Disease and Wild-Type Mice Non-Invasively: A Diffuse Optical Spectroscopy Study.Biosensors · 2022Article
- Deep learning in fNIRS: a review.Neurophotonics · 2022Review
- Screening for Alzheimer's disease using prefrontal resting-state functional near-infrared spectroscopy.Frontiers in human neuroscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The timely diagnosis of Alzheimer's disease (AD) and its prodromal stages is critically important for the patients, who manifest different neurodegenerative severity and progression risks, to take intervention and early symptomatic treatments before the brain damage is shaped. As one of the promising techniques, functional near-infrared spectroscopy (fNIRS) has been widely employed to support early-stage AD diagnosis. This study aims to validate the capability of fNIRS coupled with Deep Learning (DL) models for AD multi-class classification. First, a comprehensive experimental design, including the resting, cognitive, memory, and verbal tasks was conducted. Second, to precisely evaluate the AD progression, we thoroughly examined the change of hemodynamic responses measured in the prefrontal cortex among four subject groups and among genders. Then, we adopted a set of DL architectures on an extremely imbalanced fNIRS dataset. The results indicated that the statistical difference between subject groups did exist during memory and verbal tasks. This presented the correlation of the level of hemoglobin activation and the degree of AD severity. There was also a gender effect on the hemoglobin changes due to the functional stimulation in our study. Moreover, we demonstrated the potential of distinguished DL models, which boosted the multi-class classification performance. The highest accuracy was achieved by Convolutional Neural Network-Long Short-Term Memory (CNN-LSTM) using the original dataset of three hemoglobin types (0.909 ± 0.012 on average). Compared to conventional machine learning algorithms, DL models produced a better classification performance. These findings demonstrated the capability of DL frameworks on the imbalanced class distribution analysis and validated the great potential of fNIRS-based approaches to be further contributed to the development of AD diagnosis systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.